The revenue stands at ₹4,197.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.07 per cent from ₹3,303.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.84 per cent.
Operating Profit stands at ₹1,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.67 per cent from ₹1,078.00 crore. This corresponds to a year-on-year *(YoY) growth of 37.23 per cent.
PBDT stands at ₹1,037.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.67 per cent from ₹1,020.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.75 per cent.
Profit Before Tax stands at ₹529.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.01 per cent from ₹814.00 crore. This corresponds to a year-on-year *(YoY) decline of 20.45 per cent.
Net Profit stands at ₹364.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.68 per cent from ₹635.00 crore. This represents a 26.91 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 0.66% | 4.77% | 9.21% | 19.34% | 23.27% | 45.63% |
| Sun Pharma.Inds. | -0.79% | 0.88% | 6.10% | 9.93% | 9.13% | 13.24% |
| Divi's Lab. | -0.49% | 1.05% | -0.18% | 13.20% | 1.93% | -3.54% |
| Cipla | -0.97% | -1.46% | 4.23% | 17.21% | -2.12% | -3.81% |
| Zydus Lifesci. | -0.34% | 4.49% | 3.91% | 27.36% | 28.39% | 17.45% |
| Dr Reddy's Labs | -0.20% | 0.35% | 6.48% | 11.44% | 11.70% | 6.42% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Ameera Sushil Shah
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta